Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 4:11 pm Purchase |
2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Eventide Asset Management, LLC | 2,838,125 8.000% |
2,838,125 (New Position) |
Filing History |
| 2021-02-12 4:10 pm Purchase |
2020-12-31 | 13G | Sutro Biopharma, Inc. STRO |
Eventide Asset Management, LLC | 2,370,975 5.300% |
1,126,080 (+90.46%) |
Filing History |
| 2021-02-12 4:08 pm Purchase |
2020-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA |
Eventide Asset Management, LLC | 138,000 6.200% |
138,000 (New Position) |
Filing History |
| 2021-02-12 4:07 pm Sale |
2020-12-31 | 13G | Zogenix, Inc. ZGNX |
Eventide Asset Management, LLC | 0 0.000% |
-2,841,300 (Position Closed) |
Filing History |
| 2021-02-12 4:07 pm Purchase |
2020-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Eventide Asset Management, LLC | 165,710 7.500% |
165,710 (New Position) |
Filing History |
| 2021-02-12 4:06 pm Purchase |
2020-12-31 | 13G | Chiasma, Inc. CHMA |
Eventide Asset Management, LLC | 3,000,326 5.200% |
3,000,326 (New Position) |
Filing History |
| 2021-02-12 4:05 pm Purchase |
2020-12-31 | 13G | Annexon, Inc. ANNX |
Eventide Asset Management, LLC | 2,004,616 5.300% |
2,004,616 (New Position) |
Filing History |